• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Anders Chen, MD

Latest:

Healthcare Reform With a Safety Net: Lessons From San Francisco

San Francisco is attempting to expand health insurance coverage and access to care while also supporting its healthcare safety net.


Brandon K. Koretz, MD

Latest:

Nurse Practitioner Comanagement for Patients in an Academic Geriatric Practice

Nurse practitioner comanagment improved quality of care for 5 chronic conditions in an academic geriatrics practice.



Bruce R. Schackman, PhD

Latest:

Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient Detoxification

The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).



Catherine DesRoches, DrPH

Latest:

The Role of Health IT and Delivery System Reform in Facilitating Advanced Care Delivery

In 2012, electronic health record use and participation in accountable care organization or patient-centered medical home initiatives were associated with performing care processes expected to improve healthcare outcomes.


Eric P. Bargman, PhD

Latest:

Retail Clinic Versus Office Setting: Do Patients Choose Appropriate Providers?

Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.


Christina M. Soerensen, MPH

Latest:

Episode of Care Analysis Reveals Sources of Variations in Costs

Costs of potentially avoidable complications have significantly more variation than costs of typical care in selected chronic and procedural episodes.


Mack Harris, BA

Latest:

Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCL

An economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).


Susan M. Shetterly, MS

Latest:

Improvements in Access and Care Through the Affordable Care Act

Affordable Care Act exchange enrollees in California and Colorado reported significant improvements in access to care and fewer barriers to receiving care due to costs.


Lynn M. Ackerson, PhD

Latest:

The FLU-FIT Program: An Effective Colorectal Cancer Screening Program for High Volume Flu Shot Clinics

Offering home fecal immunochemical tests to eligible patients during influenza vaccination clinic increases colorectal cancer screening rates.


Gregory Glauser, BS

Latest:

LACE+ Index as a Predictor of 90-Day Plastic Surgery Outcomes

Patients with higher LACE+ index scores have significantly greater risk of unplanned readmission, emergency department visits, and reoperation after plastic surgery.




Rashid Kazerooni, PharmD, BCPS

Latest:

New Start Versus Continuing Users on Aripiprazole: Implications for Policy

New starts on aripiprazole were less adherent than continuing users. Prescriptions for 90-day supplies should be reserved for patients who have established effectiveness and tolerance.


Sandra L. Tunis, PhD

Latest:

Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States

For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.



Gregory D. Berg, PhD

Latest:

An Intervention for VA Patients With Congestive Heart Failure

An intervention of variable intensity for congestive heart failure showed some improvements but no survival effect, suggesting a tradeoff between intervention cost and intensity and survival benefit.



Deborah Walter, MPA

Latest:

Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

Higher cost sharing is associated with reduced branded antidepressant initiation among patients trying generic therapy. Dynamic benefit designs could enhance access to branded medications when appropriate.


Tyler Jung, MD

Latest:

Home Care Program for Patients at High Risk of Hospitalization

Randomized controlled trial of a home care program for managed care patients resulted in lower probability of hospital admission and greater patient satisfaction with care.





John M. Stevens, MD

Latest:

How Do Providers Prioritize Prevention? A Qualitative Study

Primary care providers utilize many strategies for prioritizing preventive care during time-constrained clinical encounters, in addition to being prompted by clinical reminders.



Hope Warshaw, MMSc, RD, CDE

Latest:

Community as Part of the Prescription: Social Media in Diabetes Care

This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.




Janet Chaisson, BS

Latest:

Association of Co-pay Elimination With Medication Adherence and Total Cost

This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.

© 2024 MJH Life Sciences
AJMC®
All rights reserved.